HU229582B1 - Compound for use as a reference in the analysis of levosimendan samples - Google Patents

Compound for use as a reference in the analysis of levosimendan samples

Info

Publication number
HU229582B1
HU229582B1 HU0102020A HUP0102020A HU229582B1 HU 229582 B1 HU229582 B1 HU 229582B1 HU 0102020 A HU0102020 A HU 0102020A HU P0102020 A HUP0102020 A HU P0102020A HU 229582 B1 HU229582 B1 HU 229582B1
Authority
HU
Hungary
Prior art keywords
analysis
compound
levosimendan
samples
levosimendan samples
Prior art date
Application number
HU0102020A
Other languages
English (en)
Inventor
Reijo Baeckstroem
Tuula Heinonen
Tuula Hauta-Aho
Original Assignee
Orion Corp Id No 1999212 6
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Corp Id No 1999212 6 filed Critical Orion Corp Id No 1999212 6
Publication of HUP0102020A2 publication Critical patent/HUP0102020A2/hu
Publication of HUP0102020A3 publication Critical patent/HUP0102020A3/hu
Publication of HU229582B1 publication Critical patent/HU229582B1/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32—Oxygen atoms
    • C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/04—Preparation or injection of sample to be analysed
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/04—Preparation or injection of sample to be analysed
    • G01N2030/042—Standards
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/145555—Hetero-N
    • Y10T436/147777—Plural nitrogen in the same ring [e.g., barbituates, creatinine, etc.]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
HU0102020A 1998-06-18 1999-06-18 Compound for use as a reference in the analysis of levosimendan samples HU229582B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI981428A FI104718B (fi) 1998-06-18 1998-06-18 [[4-(2-atsido-3-metyyli-5-oksotetrahydrofuran-2-yyli)fenyyli]hydratsono]propaanidinitriili käytettäväksi referenssiaineena levosimendaanierien analyysissä
PCT/FI1999/000539 WO1999065888A2 (en) 1998-06-18 1999-06-18 A reference compound for use in the analysis of levosimendan batches

Publications (3)

Publication Number Publication Date
HUP0102020A2 HUP0102020A2 (hu) 2001-12-28
HUP0102020A3 HUP0102020A3 (en) 2002-04-29
HU229582B1 true HU229582B1 (en) 2014-02-28

Family

ID=8552039

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0102020A HU229582B1 (en) 1998-06-18 1999-06-18 Compound for use as a reference in the analysis of levosimendan samples

Country Status (28)

Country Link
US (1) US6340764B1 (hu)
EP (1) EP1087956B1 (hu)
JP (1) JP4550279B2 (hu)
KR (1) KR100661772B1 (hu)
CN (1) CN1129590C (hu)
AR (1) AR018879A1 (hu)
AT (1) ATE253566T1 (hu)
AU (1) AU755699B2 (hu)
BR (1) BR9911230A (hu)
CA (1) CA2334864C (hu)
CZ (1) CZ298659B6 (hu)
DE (1) DE69912604D1 (hu)
EA (1) EA002854B1 (hu)
ES (1) ES2211113T3 (hu)
FI (1) FI104718B (hu)
HK (1) HK1032779A1 (hu)
HR (1) HRP20000866B1 (hu)
HU (1) HU229582B1 (hu)
ID (1) ID29239A (hu)
IL (1) IL139964A (hu)
MX (1) MXPA00012436A (hu)
NO (1) NO325393B1 (hu)
NZ (1) NZ508557A (hu)
PL (1) PL201772B1 (hu)
RS (1) RS49929B (hu)
SK (1) SK284353B6 (hu)
WO (1) WO1999065888A2 (hu)
ZA (1) ZA200006993B (hu)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007532686A (ja) 2004-04-21 2007-11-15 テバ ファーマシューティカル インダストリーズ リミティド モンテルカストナトリウムを調製する方法
FR2877013A1 (fr) * 2004-10-27 2006-04-28 Assist Publ Hopitaux De Paris Indentification d'une mutation de jak2 impliquee dans la polyglobulie de vaquez
CN101213177A (zh) * 2005-07-05 2008-07-02 特瓦制药工业有限公司 孟鲁司特的纯化
CN104230816B (zh) * 2014-09-19 2017-02-15 成都新恒创药业有限公司 一种左西孟旦潜在基因毒性杂质及其制备、检测方法
CN104478809B (zh) * 2014-11-14 2016-08-17 成都新恒创药业有限公司 一种左西孟旦杂质及其制备和检测方法
CN105817632A (zh) * 2015-01-09 2016-08-03 中国科学院宁波材料技术与工程研究所 片状粉末的制备装置及方法
CN105784895B (zh) * 2015-10-30 2018-05-22 成都欣捷高新技术开发有限公司 一种用高效液相色谱仪检测左西孟旦中杂质的方法
CN111474289A (zh) * 2019-10-31 2020-07-31 武汉嘉诺康医药技术有限公司 一种利用反相色谱分离分析左西孟旦中右西孟旦的方法
JP2023507626A (ja) 2019-12-16 2023-02-24 テナックス・セラピューティクス，インコーポレイテッド 駆出率が保たれた心不全を伴う肺高血圧症（ＰＨ－ＨＦ－ｐＥＦ）を治療するためのレボシメンダン

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB383449A (en) * 1931-12-12 1932-11-17 Percy Charles Barton Improvements relating to masts, poles, or like supports and their manufacture
GB565546A (en) * 1943-04-13 1944-11-15 Leslie Frederick Reeve A pneumatically operated pickup unit for use in electric organs and the like
FI894035A (fi) * 1988-09-07 1990-03-08 Orion Yhtymae Oy Foerfarande foer framstaellning av nya substituerade pyridazinoner.
GB8903130D0 (en) * 1989-02-11 1989-03-30 Orion Yhtymae Oy Substituted pyridazinones
GB2251615B (en) * 1991-01-03 1995-02-08 Orion Yhtymae Oy (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]hydrazono]pro panedinitrile
GB2266841A (en) * 1992-05-06 1993-11-17 Orion Yhtymae Oy Compounds for use as anti-ischemic medicaments
GB9606474D0 (en) * 1996-03-27 1996-06-05 Orion Yhytmo Oy Method for obtaining pure enantiomers of a pyridazinone derivative
GB9614098D0 (en) * 1996-07-05 1996-09-04 Orion Yhtymae Oy Transdermal delivery of levosimendan
GB9915179D0 (en) * 1999-06-29 1999-09-01 Orion Corp A method for the treatment or prevention of coronary graft vasospasm

Also Published As

Publication number Publication date
FI981428A (fi) 1999-12-19
NO325393B1 (no) 2008-04-21
US6340764B1 (en) 2002-01-22
YU76700A (sh) 2002-11-15
PL347577A1 (en) 2002-04-08
FI981428A0 (fi) 1998-06-18
NO20006444D0 (no) 2000-12-15
BR9911230A (pt) 2001-03-06
HK1032779A1 (en) 2001-08-03
CZ20004555A3 (en) 2001-05-16
SK284353B6 (sk) 2005-02-04
HUP0102020A3 (en) 2002-04-29
CZ298659B6 (cs) 2007-12-12
ID29239A (id) 2001-08-16
WO1999065888A2 (en) 1999-12-23
AU755699B2 (en) 2002-12-19
IL139964A0 (en) 2002-02-10
ATE253566T1 (de) 2003-11-15
HRP20000866B1 (en) 2009-02-28
KR20010072622A (ko) 2001-07-31
EP1087956B1 (en) 2003-11-05
CA2334864A1 (en) 1999-12-23
ZA200006993B (en) 2002-02-28
EA002854B1 (ru) 2002-10-31
ES2211113T3 (es) 2004-07-01
AR018879A1 (es) 2001-12-12
AU4786399A (en) 2000-01-05
EP1087956A2 (en) 2001-04-04
CN1306527A (zh) 2001-08-01
JP4550279B2 (ja) 2010-09-22
DE69912604D1 (de) 2003-12-11
IL139964A (en) 2003-07-06
EA200100055A1 (ru) 2001-06-25
PL201772B1 (pl) 2009-05-29
CN1129590C (zh) 2003-12-03
RS49929B (sr) 2008-09-29
NO20006444L (no) 2000-12-15
WO1999065888A3 (en) 2000-01-27
MXPA00012436A (es) 2002-06-04
SK18722000A3 (sk) 2001-09-11
HUP0102020A2 (hu) 2001-12-28
JP2002518383A (ja) 2002-06-25
FI104718B (fi) 2000-03-31
NZ508557A (en) 2002-05-31
CA2334864C (en) 2008-01-15
KR100661772B1 (ko) 2006-12-28
HRP20000866A2 (en) 2001-12-31

Similar Documents

Publication Publication Date Title
HUP0102743A3 (en) Analysis system
GB9819033D0 (en) Chemical compounds VI
GB9819020D0 (en) Chemical compounds III
AU3461499A (en) Fluid sampling tool
AU4188299A (en) Fluid sampling tool
HU229582B1 (en) Compound for use as a reference in the analysis of levosimendan samples
GB9807075D0 (en) Endometrial samplers
GB9803425D0 (en) Microtome
GB9422392D0 (en) Detector for chemical analysis
GB9814008D0 (en) Method for the analysis of fluids
GB9707743D0 (en) Analysis
GB9613922D0 (en) X-ray fluorescence analysis
GB9703771D0 (en) Providing samples for chromatographics
GB2338062B (en) Heteroduplex analysis
GB9807192D0 (en) Specimen slicer
GB2340940B (en) Sample collection
GB9814715D0 (en) Fluorescence analysis
GB9815131D0 (en) Pump-out tool
EG21376A (en) Immunodiagnostic kit for human fascioliasis
GB9804780D0 (en) Microtome
GB9803715D0 (en) Sampling
TW360394U (en) Improved structure for measuring tool
TW361333U (en) Improved structure for the hand tool set
TW348436U (en) Handle structure for hand-basket
GB9824434D0 (en) Biological compounds

Legal Events

Date Code Title Description
HC9A Change of name, address

Owner name: ORION CORPORATION ID NO.1999212-6, FI

Free format text: FORMER OWNER(S): ORION CORPORATION, FI